Published in Eur J Neurol on January 31, 2011
Adenosine receptors as drug targets--what are the challenges? Nat Rev Drug Discov (2013) 1.74
Cytochrome P450 enzymes in the brain: emerging evidence of biological significance. Trends Pharmacol Sci (2011) 1.28
Caffeinated and decaffeinated coffee and tea intakes and risk of colorectal cancer in a large prospective study. Am J Clin Nutr (2012) 1.12
Environmental-genetic interactions in the pathogenesis of Parkinson's disease. Exp Neurobiol (2012) 0.92
Adenosine A2A receptor gene disruption protects in an α-synuclein model of Parkinson's disease. Ann Neurol (2012) 0.91
Early Expression of Parkinson's Disease-Related Mitochondrial Abnormalities in PINK1 Knockout Rats. Mol Neurobiol (2014) 0.90
Caffeine and Parkinson's disease: are we getting our fix on risk-modifying gene-environment interactions? Eur J Neurol (2011) 0.89
Influence of single-nucleotide polymorphisms on deferasirox C trough levels and effectiveness. Pharmacogenomics J (2014) 0.88
PharmGKB summary: caffeine pathway. Pharmacogenet Genomics (2012) 0.86
Analysis of striatal transcriptome in mice overexpressing human wild-type alpha-synuclein supports synaptic dysfunction and suggests mechanisms of neuroprotection for striatal neurons. Mol Neurodegener (2011) 0.83
PharmGKB summary: very important pharmacogene information for CYP1A2. Pharmacogenet Genomics (2012) 0.80
Role of microglia adenosine A(2A) receptors in retinal and brain neurodegenerative diseases. Mediators Inflamm (2014) 0.80
Increased genetic diversity of ADME genes in African Americans compared with their putative ancestral source populations and implications for pharmacogenomics. BMC Genet (2014) 0.77
Genetic Profile, Environmental Exposure, and Their Interaction in Parkinson's Disease. Parkinsons Dis (2016) 0.76
An attempt to replicate interaction between coffee and CYP1A2 gene in connection to Parkinson's disease. Eur J Neurol (2011) 0.76
Coffee, Genetic Variants, and Parkinson's Disease: Gene-Environment Interactions. J Caffeine Res (2015) 0.75
Can coffee consumption lower the risk of Alzheimer's disease and Parkinson's disease? A literature review. Arch Med Sci (2016) 0.75
The Pael-R gene does not mediate the changes in rotenone-induced Parkinson's disease model cells. Neural Regen Res (2014) 0.75
The Role of DNA Methylation and Histone Modifications in Neurodegenerative Diseases: A Systematic Review. PLoS One (2016) 0.75
Population Structure of UK Biobank and Ancient Eurasians Reveals Adaptation at Genes Influencing Blood Pressure. Am J Hum Genet (2016) 0.75
Effects of adenosine receptor antagonists in MPTP mouse model of Parkinson's disease: mitochondrial DNA integrity. Arch Med Sci (2017) 0.75
Genetic polymorphisms of cytochrome P450-1A2 (CYP1A2) among Emiratis. PLoS One (2017) 0.75
Consed: a graphical tool for sequence finishing. Genome Res (1998) 59.36
A data-based approach to diet questionnaire design and testing. Am J Epidemiol (1986) 12.68
What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology (1992) 6.03
The Agricultural Health Study. Environ Health Perspect (1996) 5.72
Core assessment program for intracerebral transplantations (CAPIT). Mov Disord (1992) 5.51
Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am J Epidemiol (2003) 5.00
A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Ann Neurol (2002) 3.87
The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993. Am J Epidemiol (1995) 3.00
Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA (2000) 2.89
Functional significance of a C-->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. Br J Clin Pharmacol (1999) 2.57
Coffee, CYP1A2 genotype, and risk of myocardial infarction. JAMA (2006) 2.40
Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc Natl Acad Sci U S A (1989) 2.25
Clinical characteristics in early Parkinson's disease in a central California population-based study. Mov Disord (2005) 2.19
Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease. J Neurosci (2001) 1.90
Association between A2a receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology (2003) 1.65
Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1. Pharmacogenetics (1992) 1.31
Plasma caffeine metabolite ratio (17X/137X) in vivo associated with G-2964A and C734A polymorphisms of human CYP1A2. Pharmacogenetics (2001) 1.07
Novel neuroprotection by caffeine and adenosine A(2A) receptor antagonists in animal models of Parkinson's disease. J Neurol Sci (2006) 1.01
Adenosine deaminase and adenosine receptor polymorphisms in aspirin-intolerant asthma. Respir Med (2008) 0.97
Multiple comparisons between two groups on multiple Bernoulli outcomes while accounting for covariates. Stat Med (2005) 0.95
Environmental risk factors for Parkinson's disease in an urban multiethnic community. Neurology (1998) 0.94
Association between caffeine intake and risk of Parkinson's disease among fast and slow metabolizers. Pharmacogenet Genomics (2007) 0.94
Caffeine's neuroprotection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity shows no tolerance to chronic caffeine administration in mice. Neurosci Lett (2002) 0.93
Coffee, caffeine-related genes, and Parkinson's disease: a case-control study. Mov Disord (2008) 0.89
Genetic and pharmacological inactivation of the adenosine A2A receptor attenuates 3-nitropropionic acid-induced striatal damage. J Neurochem (2004) 0.86
Exploring an interaction of adenosine A2A receptor variability with coffee and tea intake in Parkinson's disease. Am J Med Genet B Neuropsychiatr Genet (2006) 0.83
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
The use of analytical isoelectric focusing for detection and identification of beta-lactamases. J Gen Microbiol (1975) 19.91
Updated research nosology for HIV-associated neurocognitive disorders. Neurology (2007) 16.18
A gene map of the human genome. Science (1996) 14.32
Attachment of a 40-base-pair G + C-rich sequence (GC-clamp) to genomic DNA fragments by the polymerase chain reaction results in improved detection of single-base changes. Proc Natl Acad Sci U S A (1989) 13.66
A physical map of 30,000 human genes. Science (1998) 12.43
A physical map of the human genome. Nature (2001) 12.39
Detection and localization of single base changes by denaturing gradient gel electrophoresis. Methods Enzymol (1987) 10.90
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Influence of education and occupation on the incidence of Alzheimer's disease. JAMA (1994) 8.43
Effects of beta-lactamase from gram-negative organisms on cephalosporins and penicillins. Antimicrob Agents Chemother (Bethesda) (1968) 8.23
Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science (1996) 8.06
The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA (1998) 7.81
Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med (2009) 7.53
Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet (1996) 7.10
Construction and analysis of simian virus 40 origins defective in tumor antigen binding and DNA replication. Proc Natl Acad Sci U S A (1980) 7.04
Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology (2006) 6.86
Nearly all single base substitutions in DNA fragments joined to a GC-clamp can be detected by denaturing gradient gel electrophoresis. Nucleic Acids Res (1985) 6.52
Fine structure genetic analysis of a beta-globin promoter. Science (1986) 6.36
Detection of single base substitutions by ribonuclease cleavage at mismatches in RNA:DNA duplexes. Science (1985) 6.35
Structure and variability of human chromosome ends. Mol Cell Biol (1990) 6.18
Detection of single base substitutions in total genomic DNA. Nature (1985) 5.99
Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology (2001) 5.98
Parkinson disease in twins: an etiologic study. JAMA (1999) 5.45
Radiation hybrid mapping: a somatic cell genetic method for constructing high-resolution maps of mammalian chromosomes. Science (1990) 5.35
A genomic screen of autism: evidence for a multilocus etiology. Am J Hum Genet (1999) 4.96
SV40 gene expression is modulated by the cooperative binding of T antigen to DNA. Cell (1981) 4.64
Diagnosis of dementia in a heterogeneous population. Development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education. Arch Neurol (1992) 4.63
Prevalence of dementia in older Japanese-American men in Hawaii: The Honolulu-Asia Aging Study. JAMA (1996) 4.40
Effects of walking on mortality among nonsmoking retired men. N Engl J Med (1998) 4.33
Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol Aging (2000) 4.22
Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology (2010) 4.06
Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology (2005) 4.04
Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease. Neurology (2007) 3.97
A general method for saturation mutagenesis of cloned DNA fragments. Science (1985) 3.94
Sources of variance in 24-hour dietary recall data: implications for nutrition study design and interpretation. Am J Clin Nutr (1979) 3.84
Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel. Science (1991) 3.73
An STS-based radiation hybrid map of the human genome. Genome Res (1997) 3.57
Frequency and characteristics of silent dementia among elderly Japanese-American men. The Honolulu-Asia Aging Study. JAMA (1997) 3.55
Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up. Am J Psychiatry (2000) 3.54
Frequency of bowel movements and the future risk of Parkinson's disease. Neurology (2001) 3.50
Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol (2001) 3.43
The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. JAMA (1995) 3.39
Neuropsychological detection and characterization of preclinical Alzheimer's disease. Neurology (1995) 3.37
Affinities of penicillins and cephalosporins for the penicillin-binding proteins of Escherichia coli K-12 and their antibacterial activity. Antimicrob Agents Chemother (1979) 3.27
Smoking duration, intensity, and risk of Parkinson disease. Neurology (2010) 3.19
Predicting time to nursing home care and death in individuals with Alzheimer disease. JAMA (1997) 3.17
Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology (2003) 3.14
When will nondifferential misclassification of an exposure preserve the direction of a trend? Am J Epidemiol (1994) 3.13
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology (2012) 3.12
Beta-lactamase assays. Methods Enzymol (1975) 3.06
The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993. Am J Epidemiol (1995) 3.00
Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community. Arch Gen Psychiatry (1996) 2.99
Comparison of assay techniques for beta-lactamase activity. Anal Biochem (1973) 2.96
Depression, intellectual impairment, and Parkinson disease. Neurology (1981) 2.96
Rates of dementia in three ethnoracial groups. Int J Geriatr Psychiatry (1999) 2.92
Modification of the melting properties of duplex DNA by attachment of a GC-rich DNA sequence as determined by denaturing gradient gel electrophoresis. Nucleic Acids Res (1985) 2.90
Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA (2000) 2.89
Competition of beta-lactam antibiotics for the penicillin-binding proteins of Pseudomonas aeruginosa, Enterobacter cloacae, Klebsiella aerogenes, Proteus rettgeri, and Escherichia coli: comparison with antibacterial activity and effects upon bacterial morphology. Antimicrob Agents Chemother (1979) 2.89
Pilot association study of the beta-glucocerebrosidase N370S allele and Parkinson's disease in subjects of Jewish ethnicity. Mov Disord (2005) 2.88
DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology (2007) 2.86
Genetic linkage studies suggest that Alzheimer's disease is not a single homogeneous disorder. Nature (1990) 2.80
Mater, a maternal effect gene required for early embryonic development in mice. Nat Genet (2000) 2.73
Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1) Science (1996) 2.73
Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. Genome Res (2001) 2.66
A potassium channel mutation in weaver mice implicates membrane excitability in granule cell differentiation. Nat Genet (1995) 2.63
beta(2)-Glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: the honolulu heart program. Stroke (2001) 2.60
Inverse relationship between education and parietotemporal perfusion deficit in Alzheimer's disease. Ann Neurol (1992) 2.59
Thottapalayam virus: a presumptive arbovirus isolated from a shrew in India. Indian J Med Res (1971) 2.52
Using pooled exposure assessment to improve efficiency in case-control studies. Biometrics (1999) 2.51
Source of variance in 24-hour dietary recall data: implications for nutrition study design and interpretation. Carbohydrate sources, vitamins, and minerals. Am J Clin Nutr (1983) 2.43
Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study. Neurology (2002) 2.42
Purification of beta-lactamases on QAE-sephadex. Biochim Biophys Acta (1973) 2.41
Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease. Neurology (2007) 2.41
Concurrent isolation from patient of two arboviruses, Chikungunya and dengue type 2. Science (1967) 2.38
Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc Natl Acad Sci U S A (2005) 2.38
Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial. Protocol 18 Aredia Breast Cancer Study Group. J Clin Oncol (1999) 2.29
Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study. Neurology (2012) 2.26
Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Honolulu-Asia aging Study. Neurobiol Aging (2000) 2.26
Association of vitamin E and C supplement use with cognitive function and dementia in elderly men. Neurology (2000) 2.26
Frequency of LRRK2 mutations in early- and late-onset Parkinson disease. Neurology (2006) 2.25
Brain aging and midlife tofu consumption. J Am Coll Nutr (2000) 2.25
Increased risk of Alzheimer's disease in mothers of adults with Down's syndrome. Lancet (1994) 2.24
Relationship between lifetime occupation and parietal flow: implications for a reserve against Alzheimer's disease pathology. Neurology (1995) 2.24
A potential novel mechanism for precocious puberty in juvenile hypothyroidism. J Clin Endocrinol Metab (1995) 2.22
Analysis of the site in CD4 that binds to the HIV envelope glycoprotein. J Immunol (1990) 2.21